Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with high morbidity and
mortality worldwide. To date, limited therapeutic achievements targeting cell proliferation …

While the morphology and function of cells of the exocrine and endocrine pancreas have
been studied over several centuries, one important cell type in the gland, the pancreatic …

Pancreatic stellate cells (PSCs) were identified in the early 1980s, but received much
attention after 1998 when the methods to isolate and culture them from murine and human …

Research on obesity-and diabetes mellitus (DM)-related carcinogenesis has expanded
exponentially since these two diseases were recognized as important risk factors for …

The destruction of cells using the mechanical activation of magnetic nanoparticles with low-
frequency magnetic fields constitutes a recent and interesting approach in cancer therapy …

Pancreatic fibrosis is a complication of chronic pancreatitis and is a prominent feature of
pancreatic cancer. Pancreatic fibrosis is commonly observed in patients with prolonged …

A workshop sponsored by the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) and the National Cancer Institute (NCI) on ''Pancreatitis-Diabetes …

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized
by its sudden manifestation, rapid progression, poor prognosis, and limited therapeutic …

Simple Summary With the mortality rate of pancreatic cancer predicted to rise over the
coming years, it is essential that effective treatment strategies are developed as soon as …

Background The prognosis of pancreatic cancer remains desperately poor, with little
progress made over the past 30 years despite the development of new combination …